Literature DB >> 31187260

Chronic treatment with C-type natriuretic peptide impacts differently in the aorta of normotensive and hypertensive rats.

Carolina Caniffi1,2, Flavia M Cerniello3,4, Gonzalo Bouchet3,4, María L Sueiro3,4, Analía Tomat3,4, Daniel González Maglio5,6, Jorge E Toblli7, Cristina Arranz3,4.   

Abstract

The aim of this study was to determine whether exogenous administration of C-type natriuretic peptide (CNP) induces functional and morphological vascular changes in spontaneously hypertensive rats (SHR) compared with normotensive rats. Male 12-week-old normotensive Wistar and SHR were administered with saline (NaCl 0.9%) or CNP (0.75 μg/h/100 g) for 14 days (subcutaneous micro-osmotic pumps). Systolic blood pressure (SBP) was measured in awake animals and renal parameters were evaluated. After decapitation, the aorta was removed, and vascular morphology, profibrotic markers, and vascular reactivity were measured. In addition, nitric oxide (NO) system and oxidative stress were evaluated. After 14-days of treatment, CNP effectively reduced SBP in SHR without changes in renal function. CNP attenuated vascular remodeling in hypertensive rats, diminishing both profibrotic and pro-inflammatory cytokines. Also, CNP activated the vascular NO system and exerted an antioxidant effect in aortic tissue of both groups, diminishing superoxide production and thiobarbituric acid-reactive substances, and increasing glutathione content. These results show that chronic treatment with CNP attenuates the vascular damage development in a model of essential hypertension, inducing changes in fibrotic, inflammatory, oxidative, and NO pathways that could contribute to beneficial long-term effects on vascular morphology, extracellular matrix composition, and function. The knowledge of these effects of CNP could lead to improved therapeutic strategies to not only control BP but also reduce vascular damage, primarily responsible for the risk of cardiovascular events.

Entities:  

Keywords:  Blood pressure; Fibrosis; Natriuretic peptides; Nitric oxide; Oxidative stress; Vascular remodeling

Mesh:

Substances:

Year:  2019        PMID: 31187260     DOI: 10.1007/s00424-019-02287-y

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  40 in total

Review 1.  TGF-betas and TGF-beta receptors in atherosclerosis.

Authors:  T A McCaffrey
Journal:  Cytokine Growth Factor Rev       Date:  2000 Mar-Jun       Impact factor: 7.638

2.  Decreased L-arginine-nitric oxide pathway in cultured myoblasts from spontaneously hypertensive versus normotensive Wistar-Kyoto rats.

Authors:  G Dubois
Journal:  FEBS Lett       Date:  1996-09-02       Impact factor: 4.124

3.  C-type natriuretic peptide effects on cardiovascular nitric oxide system in spontaneously hypertensive rats.

Authors:  Carolina Caniffi; Rosana Elesgaray; Mariela Gironacci; Cristina Arranz; María Angeles Costa
Journal:  Peptides       Date:  2010-04-02       Impact factor: 3.750

4.  Vascular cell apoptosis: cell type-specific modulation by transforming growth factor-beta1 in endothelial cells versus smooth muscle cells.

Authors:  M J Pollman; L Naumovski; G H Gibbons
Journal:  Circulation       Date:  1999-04-20       Impact factor: 29.690

5.  Redox-mediated activation of latent transforming growth factor-beta 1.

Authors:  M H Barcellos-Hoff; T A Dix
Journal:  Mol Endocrinol       Date:  1996-09

6.  Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines.

Authors:  R De Caterina; P Libby; H B Peng; V J Thannickal; T B Rajavashisth; M A Gimbrone; W S Shin; J K Liao
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

7.  C-type natriuretic peptide ameliorates monocrotaline-induced pulmonary hypertension in rats.

Authors:  Takefumi Itoh; Noritoshi Nagaya; Shinsuke Murakami; Takafumi Fujii; Takashi Iwase; Hatsue Ishibashi-Ueda; Chikao Yutani; Masakazu Yamagishi; Hiroshi Kimura; Kenji Kangawa
Journal:  Am J Respir Crit Care Med       Date:  2004-08-27       Impact factor: 21.405

8.  Differential regulation of nitric oxide synthases and their allosteric regulators in heart and vessels of hypertensive rats.

Authors:  Alina Piech; Chantal Dessy; Xavier Havaux; Olivier Feron; Jean-Luc Balligand
Journal:  Cardiovasc Res       Date:  2003-02       Impact factor: 10.787

9.  Effect of AT1 receptor antagonism on vascular and circulating inflammatory mediators in SHR: role of NF-kappaB/IkappaB system.

Authors:  David Sanz-Rosa; M Pilar Oubiña; Eva Cediel; Natalia de Las Heras; Onofre Vegazo; Javier Jiménez; Vicente Lahera; Victoria Cachofeiro
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-08-12       Impact factor: 4.733

10.  Upregulation of the angiotensin-converting enzyme 2/angiotensin-(1-7)/Mas receptor axis in the heart and the kidney of growth hormone receptor knock-out mice.

Authors:  Jorge F Giani; Johanna G Miquet; Marina C Muñoz; Valeria Burghi; Jorge E Toblli; Michal M Masternak; John J Kopchick; Andrzej Bartke; Daniel Turyn; Fernando P Dominici
Journal:  Growth Horm IGF Res       Date:  2012-09-02       Impact factor: 2.372

View more
  1 in total

Review 1.  Endogenous Vasoactive Peptides and Vascular Aging-Related Diseases.

Authors:  Yao Chen; Yongfen Qi; Weiwei Lu
Journal:  Oxid Med Cell Longev       Date:  2022-10-03       Impact factor: 7.310

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.